Safety, Tolerability, and Pharmacokinetics of HBM9378 (SKB378/WIN378), a Fully Human IgG1 Monoclonal Antibody Against TSLP After Single Ascending Doses in Chinese Healthy Subjects

20260 citationsJournal Articlegold Open Access

Authors

This trial was registered on ClinicalTrials.gov (NCT05790694) and on the China Center for Drug Evaluation (CDE) platform (CTR20221961).

Published in: Drug Design Development and Therapy

Volume Volume 20, pp. 1-13

Field-Weighted Citation Impact: 0.00